Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-007309
Filing Date
2024-02-27
Accepted
2024-02-27 17:08:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A arwr-draft14alanguage22724.htm DEFA14A 17470
2 image_0.jpg GRAPHIC 59996
  Complete submission text file 0001628280-24-007309.txt   101534
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 24688320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)